Moderna accelerates its establishment in Europe

Second round in the battle against the Covid. New versions of booster vaccines from Moderna and Pfizer were approved by US health authorities on Wednesday. These new generation vaccines, called bivalent, target both the original strain of the virus that appeared in China and that of Omicron. The objective is to start a new recall campaign in the next few days.

These recalls are examined Thursday by the European Medicines Agency. Moderna’s vaccine, which has a head start on its main competitor, has already received the green light from the United Kingdom, Switzerland and Australia. “It is safe and highly effective, we hammer at the American biotech. It will combat dominant Omicron sub-variants, but also expand protection against other variants.»

Read alsoJacques-Olivier Martin: “Moderna’s snub to France”

For Moderna, the timing is ideal. “The number of cases has stabilized, which allows health authorities to breathe, says a spokesperson. It’s the good one…